{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Hepatitis C Virus Infection in Pregnancy: An Update

Activity Steps

Purpose of Activity

To review the existing data about hepatitis C virus in pregnancy and the natural history of perinatally acquired hepatitis C virus, as well as treatment options during pregnancy, with a specifi c focus on safety of the direct acting antiviral agents during pregnancy and lactation in animal studies.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Recall the characteristics, risk factors, and historical treatment protocols for hepatitis C virus infection.
  2. Summarize the existing evidence about vertical transmission of hepatitis C virus infection and proposed treatment options during and after pregnancy.
Price: $15.00


  • ANCC 1.5 CH / 0.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours (APH)

Test Code: GN0120A
Published: Jan/Feb 2020
Expires: 12/3/2021
Required Passing Score: 13/18 (72%)
Authors: Sibel Altinbas, MD; Jacinta A. Holmes, MD, PhD; Akif Altinbas, MD